Table 2.

Kinase activity (%) of the tested compounds (15a–l) over VEGFR-2, CDK-1/cyclin B and HER-2.

Compound	% Activity
	VEGFR-2	CDK-1/cyclin B	HER-2
15a	96	91	95
15b	100	100	93
15c	100	91	99
15d	91	85	90
15e	98	88	86
15f	96	91	100
15g	100	92	83
15h	100	95	97
15i	85	89	87
15j	90	91	93
15k	90	92	92
15l	92	51	52